Our cell-cell interaction analysis highlighted CXCR5+ B cells as the dominant antigen presenting cells in ICI OT-R TME, presenting antigens to both tumor-reactive CD8 T cells and CD4 Tfh cells and through MHC I and MHC II pathways, respectively. The gene discussed is CD8A; the disease is neoplasm.